Lantheus Holdings Prices IPO At $6, Below The Range

Published: Jun 25, 2015

Lantheus Holdings, which sells medical imaging agents used in the diagnosis of cardiovascular diseases, raised $65 million by offering 10.8 million shares (upsized from 7.9 million shares) at $6, below the range of $8.50 to $10.50. Lantheus Holdings plans to list on the NASDAQ under the symbol LNTH. Lantheus Holdings initially filed confidentially on 3/25/2014. Credit Suisse, Jefferies, RBC Capital Markets and Wells Fargo Securities acted as lead managers on the deal.

Help employers find you! Check out all the jobs and post your resume.

Back to news